Abstract
Non-adherence to medication is the key obstacle to HIV treatment success. The group at highest risk of non-adherence is adolescents, but relatively little is known about risk factors for and protective factors against poor adherence in this age-group. We undertook a cross-sectional study of 262 HIV-infected adolescents aged 10–19 on antiretroviral therapy at two clinics in Harare, Zimbabwe to investigate personal and system-level factors associated with optimal self-reported adherence. Suboptimal adherence was common with only 101(39%) reporting “excellent” adherence. Having the guardian present at each clinical encounter, comfort with asking questions to the health provider and participating in group sessions led by a professional facilitator were all significantly associated with excellent adherence (p<0.05). Strengthening the parent-child dyad and professional-led groups as strategies to improve adherence should be evaluated.
Introduction
Suboptimal adherence to antiretroviral therapy for human immunodeficiency virus (HIV) infection leads to virologic failure (Gross, Bilker, Friedman, & Strom, 2001), drug resistance (Gardner, Burman, Steiner, Anderson, & Bangsberg, 2009), and the need for more complex regimens. In resource-limited settings, suboptimal adherence can quickly rob patients of effective treatment options. Many adherence interventions have been studied in adults (Simoni, Amico, Smith, & Nelson, 2010). Few have demonstrated both adherence and virologic benefits. Much less data are available on interventions in adolescents (Thompson et al., 2012).
Ninety percent of the estimated three million HIV infected children live in sub-Saharan Africa (“Global Report: UNAIDS Report on the Global AIDS Epidemic,” 2012), and ART has resulted in increasing numbers of children surviving to adolescence. Unfortunately, compared to other ages, adolescents have the highest rates of suboptimal adherence and treatment failure (Flynn et al., 2007; Nachega et al., 2009). Adolescents with HIV are challenged by psychosocial issues including increased responsibility for medications, (Berg et al., 2011), decreased family support as they are perceived to be “of age” (Williams, Mukhopadhyay, Dowell, & Coyle, 2007), psychological reactance against authority (Hong, Giannakopoulos, Laing, & Williams, 1994), HIV-related stigma (Fielden, Chapman, & Cadell, 2011), poor outcome expectancy (Rudy, Murphy, Harris, Muenz, & Ellen, 2009; Tamaroff, Festa, Adesman, & Walco, 1992), and limited orientation towards consequences of actions (Reisner et al., 2009).
Determinants of adherence can be both individual and system factors. For adolescents, relationships with responsible adults may play a larger role than do social supporters in older patients (Naar-King et al., 2013). We aimed to identify risk/protective factors for non-adherence in adolescents in Harare, Zimbabwe, a country with an HIV prevalence of approximately 10% in pregnant women ages 15–24 years and an annual incidence of 1% (“Global AIDS Response Country Progress Report: Zimbabwe 2014,” 2014). We assessed potential personal and structural barriers to inform both the development and the rejection of strategies to support adherence in adolescents.
Methods
Study Site and Participants
Participants were HIV-infected adolescents aged 10–19 years and aware of their HIV status. They were consecutively surveyed from Parirenyatwa and Harare Hospital HIV clinics, the two main public sector sites primarily serving lower income patients. The Parirenyatwa Hospital site is a family clinic caring for both HIV-infected children and adults. The Harare Hospital site is a children’s clinic with transition to adult clinics around age 16 years. Both sites care for large numbers of adolescents, most of whom are on ART. All patients see a lay counselor for an adherence assessment and feedback prior to seeing the clinician. Professional counseling is available via support groups led by trained nurses and counselors (Mavhu et al., 2013).
An HIV infected young man working as a peer supporter provided a structured questionnaire to participants. The questionnaires were self-completed and placed by participants in a box to maintain anonymity.
Variables Measured
The primary outcome was self-reported adherence using a modification of the Self-Rating Scale Item (Feldman et al., 2013). The questionnaire queried about attitudes and preferences related to social support and activities they participated in related to HIV. The questionnaire is provided in the Appendix.
Analysis and Sample Size Considerations
Although this was a cross-sectional study, we conceptualized self-reported adherence as the “outcome” and dichotomized it as optimal if reported as ‘excellent.’ All other categories (very good, good, poor, very poor) were defined as suboptimal adherence given the ceiling effect inherent in self-reports (Simoni et al., 2006). The association between categorical and ordinal variables with optimal adherence was assessed using Chi-squared tests and non-parametric tests of trend, respectively. We used multivariable logistic regression to control for potential confounders. Variables were considered potential confounders if they were associated with adherence with a p value <0.1. Age and sex were included in the models since they were considered potentially clinically significant confounders irrespective of association with adherence. Confounding was considered to be present if the point estimate of the relation between the primary variable and adherence changed by >15% when the potential confounder was included in the models. We targeted enrolment of approximately 100 patients per site (200 total) to allow for a precision of <10% around estimates of the proportion with optimal adherence.
Ethical Considerations
The study was conducted as an assessment of utilization of services and no personally identifiable information was recorded. Informed consent and documentation of assent were waived by the Medical Research Council of Zimbabwe.
Results
We enrolled 262 adolescents on antiretroviral therapy and Table 1 compares demographic and personal characteristics between the optimal and suboptimal adherence groups. 101 (39%) patients reported suboptimal adherence. Overall, there were more females than males, most adolescents were living with family and many traveled for more than an hour to their clinic appointments. The majority felt comfortable talking with their health provider, confident in their ability to take medications, and very satisfied with their care. Those with optimal adherence more commonly reported each of these factors compared to the suboptimally adherent adolescents. Travel time and sources of social support did not differ between the groups.
Table 1.
Characteristic | Overall (n=262) | Excellent Adherence (n=101) | Suboptimal Adherence (n=161) | P value |
---|---|---|---|---|
Female sex | 156 (61%) n=257 |
55 (57%) n=96 |
101 (63%) n=161 |
0.39 |
Median age in years (IQR) | 15.5 (14–17) | 15 years (13–17) | 16 years (14–17) | 0.45 |
Live with family | 245 (94%) | 98 (97%) | 147 (91%) | 0.07 |
Currently working | 16 (6%) n=260 | 5 (5%) n=101 |
11 (7%) n=159 |
>0.5 |
Social support | ||||
By family | 225 (86%) | 84 (83%) | 141 (88%) | 0.32 |
By friends | 41 (16%) | 19 (19%) | 22 (14%) | 0.26 |
By faith community | 34 (13%) | 15 (15%) | 19 (12%) | 0.48 |
By provider | 83 (32%) | 34 (34%) | 49 (30%) | >0.5 |
Use traditional healer | 31 (12%) n=259 |
8 (8%) n=99 |
23 (14%) n=161 |
0.13 |
Travel time to clinic | n=259 | n=100 | n=159 | >0.5 |
<15 minutes | 26 (10%) | 10 (10%) | 16 (10%) | |
15–30 minutes | 89 (34%) | 38 (38%) | 51 (32%) | |
30 minutes-1 hour | 87 (34%) | 29 (29%) | 58 (36%) | |
>1 hour | 57 (22%) | 23 (23%) | 34 (21%) | |
Expressed comfort asking provider questions | n=260 | n=99 | n=161 | 0.02* |
Not at all | 32 (12%) | 9 (9%) | 23 (14%) | |
Sometimes | 67 (26%) | 20 (20%) | 47 (29%) | |
Very much | 161 (62%) | 70 (70%) | 91 (57%) | |
Confidence in maintaining adherence | n=258 | n=99 | n=259 | 0.04* |
Not at all | 7 (3%) | 0 | 7 (4%) | |
Sometimes | 43 (17%) | 13 (14%) | 30 (19%) | |
Very Much | 203 (79%) | 83 (87%) | 120 (76%) | |
Belief in importance of adherence | n=259 | n=99 | n=160 | 0.25 |
Not at all | 4 (4%) | 10 (6%) | ||
Sometimes | 7 (7%) | 16 (10%) | ||
Very Much | 214 (83%) | 85 (89%) | 129 (81%) | |
Satisfied with HIV care | n=257 | n=98 | n=159 | 0.046* |
Not at all | 31 (12%) | 11 (11%) | 20 (13%) | |
Sometimes | 42 (16%) | 9 (9%) | 33 (21%) | |
Very Much | 184 (72%) | 78 (80%) | 106 (67%) |
test for trend
n – number with data available for analysis overall and by subgroup. If not listed for variable, no data was missing.
Table 2 compares clinic-level factors between the excellent and suboptimal adherence groups. Having a parent or guardian in the room during visits was more common in the excellent compared to suboptimal adherence group. For patients whose parents were always in the room, the odds ratio (OR) for excellent adherence was 2.1 (95% CI 1.3–3.5). Although uncommon, receiving contact through telephone calls or Short Messaging System if a visit was missed was more common in the adherent group with an OR of 2.4 (95% CI 1.2–4.8). Home visits were rare after missed clinic visits (Table 2). The adolescents commonly participated in group activities and individual counseling, but only group sessions conducted by trained professionals were associated with high rates of adherence. Adolescents who participated in these professionally run groups had a 1.8 times (95% CI: 1.1–3.0) the odds of excellent adherence compared with non-participants.
Table 2.
Characteristic | Overall (n=262) | Excellent Adherence (n=101) | Suboptimal Adherence (n=161) | P value |
---|---|---|---|---|
Visit frequency | n=259 | n=100 | n=159 | 0.35 |
< 4x/year | 31 (12%) | 12 (12%) | 19 (12%) | |
4x/year | 36 (14%) | 10 (10%) | 26 (16%) | |
>4x/year | 192 (74%) | 78 (78%) | 114 (72%) | |
Action Taken for Missed Visit | n=260 | n=100 | n=160 | 0.04 |
None | 146 (56%) | 49 (49%) | 97 (61%) | |
Telephone call or SMS to patient | 37 (14%) | 21 (21%) | 16 (10%) | |
Contact parent/guardian | 67 (26%) | 28 (28%) | 39 (24%) | |
Home visit | 10 (4%) | 2 (2%) | 8 (5%) | |
Parent/guardian in room for clinic visit | n=259 | n=100 | n=159 | 0.01* |
Never | 35 (14%) | 12 (12%) | 23 (14%) | |
Sometimes | 107 (41%) | 31 (31%) | 76 (48%) | |
Always | 117 (45%) | 56 (56%) | 61 (38%) | |
Participate in group meetings for HIV+ children run by professional | 145 (56%) n=260 |
64 (65%) n=99 |
81 (50%) n=161 |
0.02 |
Participate in group activities for HIV+ children | 146 (56%) n=259 |
62 (62%) n=100 |
84 (53%) n=159 |
0.15 |
Participate in peer run support group | 128 (49%) n=260 |
47 (47%) n=100 |
81 (52%) n=160 |
>0.5 |
Received individual counseling/mentoring | 138 (53%) n=259 |
54 (53%) n=101 |
84 (53%) n=158 |
>0.5 |
test for trend
n – number with data available for analysis overall and by subgroup. If not listed for variable, no data was missing.
In multivariable models, there was no change in the relation between the significantly associated variables from the univariate comparisons with adherence. Therefore, only univariate analyses are presented.
Discussion
We found that self-reported suboptimal adherence was common in these adolescents, consistent with findings of others in the setting of chronic diseases including asthma (Desai & Oppenheimer, 2011), diabetes (Palmer et al., 2011), and HIV (Nachega et al., 2009). Nachega et al. demonstrated that adolescent adherence with antiretrovirals in sub-Saharan Africa was worse than that of adults (Nachega et al., 2009). We also found that there was more direct involvement of parents/guardians in clinic visits in those with excellent adherence. A simple explanation would be that the involvement at clinic reflected greater social support by these caregivers at home. This finding is consistent with that of Mellins et al. who found that the quality of parent-child communication was associated with adherence rates in HIV infected children in the US (Mellins, Brackis-Cott, Dolezal, & Abrams, 2006).
Our findings regarding confidence and trust in providers have previously been shown to be associated with adherence in HIV-infected adults. Confidence is a measure of self-efficacy (Barclay et al., 2007), an important determinant of behavior as conceptualized in Social Cognitive Theory (Bandura, 1998). Comfort in talking with the provider is engendered by trust, which has previously also been associated with adult adherence to antiretrovirals (Altice, Mostashari, & Friedland, 2001).
The relation between counseling and adherence was mixed. Attendance at group sessions run by a professional were protective against non-adherence, but group activities run by peers and individual counseling sessions were not associated with better adherence. Although we were unable to elucidate in further detail the etiology of these differences, possibilities include implementation of ineffective strategies or poor fidelity to effective strategies due to high volume (Thurman, Haas, Dushimimana, Lavin, & Mock, 2010) and/or poor training of staff regarding children’s needs. Further, referral of those with the worst adherence problems, and thus, least likely to improve their adherence, may be responsible for the lack of effect. Group activities and interventions are commonly implemented in HIV care settings (http://www.aidstar-one.com/promising_practices_database/g3ps/teen_club_peer_support_group_hiv_positive_adolescents). However, few have been formally tested (Thompson et al., 2012).
Our study’s strengths included the large numbers of adolescents at the main sites of care for HIV-infected adolescents in Harare. This study also had several limitations. Although self-reports can identify non-adherent individuals, they typically overestimate adherence. However, we found substantial non-adherence when using the threshold of less than “excellent” adherence. Neither objective measures of adherence nor viral loads were available and hence we are unable to comment on the clinical relevance of the suboptimal adherence. In addition, more detailed information about the support groups including the content of activities and the individuals who facilitate them would help determine which aspects are most promising. Several community based support groups exist in Harare, and are run by a variety of individuals including lay community workers, peers, churches and lay counselors as well as professional groups. Unfortunately, there are limited data to determine which of these models is more or less successful at improving adherence.
In conclusion, we found non-adherence to be common in HIV infected adolescents in care in Harare and that parental involvement and group sessions led by professional staff may hold promise for further development as systematically implemented adherence interventions (Mellins, Brackis-Cott, Dolezal, & Abrams, 2004). Formal evaluation of current support programs are warranted to determine if they merit continued support and adaptation.
Acknowledgments
Dr. Lowenthal’s effort was supported by NIH K23 MH095669 and Dr. Gross’ effort was supported by the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008)
Contributor Information
Robert Gross, University of Pennsylvania Perelman School of Medicine - CCEB, 804 Blockley Hall 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021, United States.
Tsitsi Bandason, BIOMEDICAL RESEARCH AND TRAINING INSTITUTE - RESEARCH, P.O. BOX CY1753, CAUSEWAY HARARE, HARARE 004, Zimbabwe.
Lisa Langhaug, REPSSI, Harare, Zimbabwe.
Hilda Mujuru, University of Zimbabwe College of Health Sciences - Paediatrics and Child Health, Harare, Zimbabwe.
Elizabeth Lowenthal, Children’s Hospital of Philadelphia - General Pediatrics, 3535 Market Street Room 1513, Philadelphia, Pennsylvania 19104, United States.
Rashida Ferrand, Biomedical Research & Training Institute, Harare, Zimbabwe.
References
- Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.] J Acquir Immune Defic Syndr. 2001;28(1):47–58. doi: 10.1097/00042560-200109010-00008. [DOI] [PubMed] [Google Scholar]
- Bandura A. Health promotion from the perspective of social cognitive theory. Psychology & Health. 1998;13(4):623–649. [Google Scholar]
- Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, Durvasula RS. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40–49. doi: 10.1037/0278-6133.26.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berg CA, King PS, Butler JM, Pham P, Palmer D, Wiebe DJ. Parental involvement and adolescents’ diabetes management: the mediating role of self-efficacy and externalizing and internalizing behaviors. [Research Support, N.I.H., Extramural] J Pediatr Psychol. 2011;36(3):329–339. doi: 10.1093/jpepsy/jsq088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. [Research Support, Non-U.S. Gov’t Review] Curr Allergy Asthma Rep. 2011;11(6):454–464. doi: 10.1007/s11882-011-0227-2. [DOI] [PubMed] [Google Scholar]
- Feldman BJ, Fredericksen RJ, Crane PK, Safren SA, Mugavero MJ, Willig JH, Crane HM. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. [Evaluation Studies Research Support, N.I.H., Extramural] AIDS Behav. 2013;17(1):307–318. doi: 10.1007/s10461-012-0326-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fielden SJ, Chapman GE, Cadell S. Managing stigma in adolescent HIV: silence, secrets and sanctioned spaces. Cult Health Sex. 2011;13(3):267–281. doi: 10.1080/13691058.2010.525665. [DOI] [PubMed] [Google Scholar]
- Flynn PM, Rudy BJ, Lindsey JC, Douglas SD, Lathey J, Spector SA, Hughes MD. Long-term observation of adolescents initiating HAART therapy: three-year follow-up. [Research Support, N.I.H., Extramural] AIDS Res Hum Retroviruses. 2007;23(10):1208–1214. doi: 10.1089/aid.2006.0290. [DOI] [PubMed] [Google Scholar]
- Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. Aids. 2009;23(9):1035–1046. doi: 10.1097/QAD.0b013e32832ba8ec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Global AIDS Response Country Progress Report: Zimbabwe 2014. UNAIDS; 2014. [Google Scholar]
- Global Report: UNAIDS Report on the Global AIDS Epidemic. 2012. [Google Scholar]
- Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. [Clinical Trial Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.] AIDS. 2001;15(16):2109–2117. doi: 10.1097/00002030-200111090-00006. [DOI] [PubMed] [Google Scholar]
- Hong SM, Giannakopoulos E, Laing D, Williams NA. Psychological reactance: effects of age and gender. J Soc Psychol. 1994;134(2):223–228. doi: 10.1080/00224545.1994.9711385. [DOI] [PubMed] [Google Scholar]
- Mavhu W, Berwick J, Chirawu P, Makamba M, Copas A, Dirawo J, Cowan FM. Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe. [Research Support, Non-U.S. Gov’t] PLoS One. 2013;8(7):e70254. doi: 10.1371/journal.pone.0070254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. [Comparative Study Research Support, U.S. Gov’t, P.H.S.] Pediatr Infect Dis J. 2004;23(11):1035–1041. doi: 10.1097/01.inf.0000143646.15240.ac. [DOI] [PubMed] [Google Scholar]
- Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection. [Research Support, N.I.H., Extramural] Pediatr Infect Dis J. 2006;25(5):432–437. doi: 10.1097/01.inf.0000217372.10385.2a. [DOI] [PubMed] [Google Scholar]
- Naar-King S, Montepiedra G, Garvie P, Kammerer B, Malee K, Sirois PA, Nichols SL. Social ecological predictors of longitudinal HIV treatment adherence in youth with perinatally acquired HIV. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] J Pediatr Psychol. 2013;38(6):664–674. doi: 10.1093/jpepsy/jst017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] J Acquir Immune Defic Syndr. 2009;51(1):65–71. doi: 10.1097/QAI.0b013e318199072e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palmer DL, Osborn P, King PS, Berg CA, Butler J, Butner J, Wiebe DJ. The structure of parental involvement and relations to disease management for youth with type 1 diabetes. [Research Support, N.I.H., Extramural] J Pediatr Psychol. 2011;36(5):596–605. doi: 10.1093/jpepsy/jsq019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. [Research Support, N.I.H., Extramural Review] Top HIV Med. 2009;17(1):14–25. [PMC free article] [PubMed] [Google Scholar]
- Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. [Research Support, N.I.H., Extramural] AIDS Patient Care STDS. 2009;23(3):185–194. doi: 10.1089/apc.2008.0162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. [Review] Curr HIV/AIDS Rep. 2010;7(1):44–51. doi: 10.1007/s11904-009-0037-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. [Research Support, N.I.H., Extramural Review] AIDS Behav. 2006;10(3):227–245. doi: 10.1007/s10461-006-9078-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tamaroff MH, Festa RS, Adesman AR, Walco GA. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr. 1992;120(5):812–817. doi: 10.1016/s0022-3476(05)80257-4. [DOI] [PubMed] [Google Scholar]
- Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Nachega JB. Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel. [10.1059/0003-4819-156-11-201206050-00419];Ann Intern Med. 2012 doi: 10.7326/0003-4819-156-11-201206050-00419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thurman TR, Haas LJ, Dushimimana A, Lavin B, Mock N. Evaluation of a case management program for HIV clients in Rwanda. AIDS Care. 2010;22(6):759–765. doi: 10.1080/09540120903443376. [DOI] [PubMed] [Google Scholar]
- Williams B, Mukhopadhyay S, Dowell J, Coyle J. From child to adult: an exploration of shifting family roles and responsibilities in managing physiotherapy for cystic fibrosis. [Research Support, Non-U.S. Gov’t] Soc Sci Med. 2007;65(10):2135–2146. doi: 10.1016/j.socscimed.2007.07.020. [DOI] [PubMed] [Google Scholar]